BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 157 filers reported holding BIOLIFE SOLUTIONS INC in Q2 2023. The put-call ratio across all filers is 7.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,831,841 | -24.9% | 1,363,638 | +20.2% | 0.53% | -21.1% |
| Q2 2023 | $25,069,179 | +6.7% | 1,134,352 | +5.1% | 0.67% | +5.2% |
| Q1 2023 | $23,485,954 | +25.3% | 1,079,814 | +4.9% | 0.63% | +26.0% |
| Q4 2022 | $18,739,139 | -10.7% | 1,029,623 | +11.6% | 0.50% | -15.5% |
| Q3 2022 | $20,988,000 | +65.2% | 922,543 | +0.3% | 0.60% | +73.0% |
| Q2 2022 | $12,708,000 | +1.3% | 920,184 | +66.8% | 0.34% | +19.4% |
| Q1 2022 | $12,542,000 | -43.0% | 551,769 | -6.5% | 0.29% | -35.3% |
| Q4 2021 | $21,989,000 | -11.1% | 589,988 | +1.0% | 0.44% | -17.6% |
| Q3 2021 | $24,728,000 | +16.8% | 584,301 | +22.8% | 0.54% | +13.0% |
| Q2 2021 | $21,173,000 | +55.1% | 475,684 | +25.5% | 0.48% | +48.9% |
| Q1 2021 | $13,648,000 | – | 379,111 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,721,535 | $170,645,924 | 14.91% |
| Gagnon Advisors, LLC | 360,758 | $7,972,751 | 5.34% |
| Park West Asset Management LLC | 2,081,083 | $45,991,934 | 4.02% |
| Meros Investment Management, LP | 324,479 | $7,170,986 | 3.56% |
| GAGNON SECURITIES LLC | 637,576 | $14,090,429 | 2.93% |
| Mesirow Financial Investment Management, Inc. | 16,947 | $374,529 | 1.59% |
| Zweig-DiMenna Associates LLC | 256,000 | $5,657,600 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,561,443 | $34,507,882 | 0.68% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,134,352 | $25,069,179 | 0.67% |
| Penbrook Management LLC | 41,500 | $917,150 | 0.66% |